Remdesivir is a failed ebola drug that is not approved for any uses [1].
Cyproheptadine is approved for use for several conditions, including serotonin syndrome. Platelets are the usual carriers of serotonin in the blood. They arrive where they're needed and poof, release all their serotonin to facilitate clotting and inflammation.
> Serotonin [...] [in the blood] is actively taken up by blood platelets, which store it. When the platelets bind to a clot, they release serotonin, where it can serve as a vasoconstrictor or a vasodilator while regulating hemostasis and blood clotting. In high concentrations, serotonin acts as a vasoconstrictor [...] [0]
[0] https://en.wikipedia.org/wiki/Serotonin
Farid Jalali [2] is an early advocate of this protocol. I think he's a gastointestinal doc who realized that cyproheptadine's usefulness for COVID-19-induced gastrointestinal problems was also profoundly helpful for the rest of the body too.
There's a commonly-used treatment that creates inflammation. The use of this treatment is another big mistake in the standard treatments used for COVID.... But I don't have credentials. How do you point out to the professionals that their profession seems to have forgotten something important?
(This submission probably isn't going to the front page; this comment is just me making notes.)
[0] https://en.wikipedia.org/wiki/Cyproheptadine
[1] https://news.ycombinator.com/item?id=26705499
[2] https://twitter.com/farid__jalali/ (set his tweets private last week? Oh my.)